{"id":"NCT02501161","sponsor":"Novo Nordisk A/S","briefTitle":"A 104 Week Clinical Trial Comparing Long Term Glycaemic Control of Insulin Degludec/Liraglutide (IDegLira) Versus Insulin Glargine Therapy in Subjects With Type 2 Diabetes Mellitus","officialTitle":"A Clinical Trial Comparing Long Term Glycaemic Control of Insulin Degludec/Liraglutide (IDegLira) Versus Insulin Glargine Therapy in Subjects With Type 2 Diabetes Mellitus","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2016-01-31","primaryCompletion":"2018-10-03","completion":"2018-10-03","firstPosted":"2015-07-17","resultsPosted":"2019-11-27","lastUpdate":"2019-11-27"},"enrollment":1012,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Diabetes","Diabetes Mellitus, Type 2"],"interventions":[{"type":"DRUG","name":"insulin degludec/liraglutide","otherNames":[]},{"type":"DRUG","name":"insulin glargine","otherNames":[]}],"arms":[{"label":"Insulin degludec/liraglutide QD + OAD(s)","type":"EXPERIMENTAL"},{"label":"insulin glargine QD + OAD(s)","type":"ACTIVE_COMPARATOR"}],"summary":"This trial is conducted in Africa, Asia, Europe, North America and South America. The purpose is to compare long-term glycaemic control of insulin degludec/liraglutide (IDegLira) versus insulin glargine (IGlar) in insulin naïve subjects with type 2 diabetes mellitus inadequately controlled with oral anti diabetics.","primaryOutcome":{"measure":"Time From Randomisation to Inadequate Glycaemic Control and Need for Treatment Intensification","timeFrame":"Weeks 0-104 + 7 days follow-up-1 + 30 days follow-up-2","effectByArm":[{"arm":"Insulin Degludec/Liraglutide","deltaMin":null,"sd":null},{"arm":"Insulin Glargine","deltaMin":104.3,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":7},"locations":{"siteCount":143,"countries":["United States","Argentina","Brazil","Czechia","Hungary","India","Israel","Italy","Mexico","Norway","Poland","Russia","Slovakia","South Africa","Turkey (Türkiye)","United Kingdom"]},"refs":{"pmids":["31189519","36710452"],"seeAlso":["http://novonordisk-trials.com"]},"adverseEventsSummary":{"seriousAny":{"events":60,"n":506},"commonTop":["Headache","Nasopharyngitis","Influenza","Upper respiratory tract infection","Arthralgia"]}}